Teva Plagued by Low P&L Visibility and 4 Must-See Stock Analyses
Seagate Technology (NASDAQ:STX): Brean Capital continues to like both Seagate and Western Digital (NYSE:WDC) on pullbacks based on modest growth assumptions. Both companies have a Buy rating, and Brean Capital reduced its price target on Seagate to $33 from $35 and on Western Digital to $44 from $48.
Teva Pharmaceutical Industries Limited (NASDAQ:TEVA) estimates have been reduced by Canaccord ahead of the Q3 report due to lower U.S. generic revenue and low P&L visibility. The firm thinks that the company has the ability to reset 2013 expectations at its December 11 strategy meeting but said it could come as soon as the Q3 report. Shares have a Buy rating and a $50 price target.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
MICROS Systems, Inc. (NASDAQ:MCRS): According to RBC Capital, investors’ concerns regarding the effect of new tablet-based restaurant applications have caused some weakness in MICROS’ stock. The firm believes that the concerns are overdone, and it thinks that MICROS to launch its own tablet solution in 1H13, while SME point-of-sale hardware only makes up 6 percent of the company’s revenues. The firm keeps its Top Pick rating and a $62 target on the stock.
Heartware International Inc. (NASDAQ:HTWR): Canaccord recommends purchasing Heartware based on long-term growth in the VAD market and notes that the company’s decision to cease its REVIVE-IT study is immaterial. Shares have a Buy rating and a $110 price target.
Accretive Health, Inc. (NYSE:AH): After University of Minnesota Medical Center Fairview was declared Medicare compliant, Oppenheimer predicts any possible overhang from Accretive Health’s ability to gain new business will be removed. The firm maintains its Outperform rating on the stock.